Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
21.42
+0.02 (0.07%)
Mar 27, 2026, 2:15 PM EDT - Market open
DAWN Market Cap
DAWN has a market cap or net worth of $2.21 billion as of March 27, 2026. Its market cap has increased by 148.30% in one year.
Market Cap
2.21B
Enterprise Value
1.77B
1-Year Change
148.30%
Ranking
Category
Stock Price
$21.42
Market Cap Chart
Since the IPO on May 27, 2021, DAWN's market cap has increased from $965.40M to $2.21B, an increase of 129.14%. That is a compound annual growth rate of 18.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 2.21B | 131.05% |
| Dec 31, 2025 | 956.94M | -25.11% |
| Dec 31, 2024 | 1.28B | 0.54% |
| Dec 29, 2023 | 1.27B | -19.71% |
| Dec 30, 2022 | 1.58B | 51.68% |
| Dec 31, 2021 | 1.04B | 8.09% |
| May 27, 2021 | 965.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Disc Medicine | 2.37B |
| Enliven Therapeutics | 2.35B |
| Immunome | 2.31B |
| Sarepta Therapeutics | 2.28B |
| Apellis Pharmaceuticals | 2.25B |
| Oruka Therapeutics | 2.25B |
| Syndax Pharmaceuticals | 2.18B |
| Adaptive Biotechnologies | 2.15B |